📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 20:14
206 analysed today
FollowTelegram
206
Today
149,607
All-time analysed
42,901
Positive
6,659
Negative
91,372
Neutral
8,607
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Samrat Pharmachem Q1 Net Profit at ₹0.88 Cr; Swings to Profit from ₹0.23 Cr Loss YoY
Samrat Pharmachem reported a standalone revenue from operations of ₹79.76 crore for Q1 ended June 30, 2026, marking a 5.4% YoY increase and 11.1% QoQ growth. The company swung back into profitability with a net profit of ₹0.88 crore compared to a net loss of ₹0.23 crore in Q1 FY26 and a net loss of ₹2.04 crore in Q4 FY26. Profit before tax stood at ₹1.59 crore, recovering from a PBT loss of ₹1.87 crore in the preceding quarter. Diluted EPS for the quarter came in at ₹2.84 compared to ₹(0.74) YoY.
Confidence: HIGH
What changedSamrat Pharmachem returned to profitability in Q1 after reporting consecutive quarterly losses throughout FY26.
Why it mattersThe operational turnaround helps reverse the ₹3.0 crore full-year loss of FY26 and provides margin relief for the micro-cap chemical manufacturer.
Revenue from operations: ₹7,976.10 lakhsProfit before tax: ₹158.53 lakhsNet Profit (PAT): ₹87.60 lakhsEPS: ₹2.84
📅 Short termLikely to be viewed positively in the near term as earnings rebound back into positive territory after four loss-making quarters.
📈 Long termStructural sustainability relies on expanding operating margins in its single segment of pharmaceutical chemicals, where raw material costs remain high relative to revenue.
⚠ Risk flags
- High sensitivity to raw material prices (cost of materials consumed remains ~98% of revenue)
- Historical earnings and margin volatility
Key Highlights
Revenue from operations grew 5.43% YoY to ₹79.76 crore (₹7,976.10 lakhs) vs ₹75.65 crore in Q1 FY26
Turned profitable with standalone PAT of ₹0.88 crore (₹87.60 lakhs) vs net loss of ₹0.23 crore YoY and ₹2.04 crore QoQ
Profit before tax stood at ₹1.59 crore (₹158.53 lakhs) vs ₹0.21 crore in Q1 FY26
Diluted EPS improved to ₹2.84 per share from ₹(0.74) in the prior-year period
👀 What to Watch
Monitor whether the operational profitability and gross margin recovery can be sustained across subsequent quarters amid raw material price fluctuations.
